Fact CheckerSign in

NCT07026955Completed

Colorectal Cancer in Young Adults: Study of Incidence, Survival, and Prognostic Factors in Tarragona, Spain

Source: ClinicalTrials.gov · Last updated 18 Jun 2025

Brief summary (registry, in English)

We conducted an observational, descriptive, longitudinal and retrospective study of 59 patients under 50 years of age diagnosed with CRC in the province of Tarragona, between 2019 and 2024. Sociodemographic, clinical, anatomopathological and evolutionary variables provided from the data collected in the registry of the Colorectal Cancer Committee of the Joan XXIII University Hospital (HJ23) were analyzed.

Status (registry)
Completed
Study type
Observational
Enrollment
59 (actual)
First submitted
2 Jun 2025
Start date
1 Oct 2024
Primary completion date
1 May 2025
Lead sponsor
HJ23
NCT number
NCT07026955

What you commit to

  • Study type: Observational
  • Participants enrolled: 59
  • From 1 Oct 2024 to the primary completion date, 1 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • other non-neoplastic colorectal conditions.

Age

  • over 50 years of age,

Other

  • Primary tumors of non-colorectal origin
  • individuals diagnosed with polyps with low-grade dysplasia, hyperplastic polyps

Who the study is looking for

  • patients under 50 years of age
  • diagnosed: colorectal cancer

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Universitario de Tarragona Joan XXIII
Coordinator of this site? Confirm its status
TarragonaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.